Ghent University to Use Roche LightCycler 1536 for HT PCR-based Cancer Studies
April 22, 2010
Ghent University to Use Roche LightCycler 1536 for HT PCR-based Cancer Studies
Although Roche said that it signed an agreement with Ghent University in general, the instrument will primarily be used in the laboratory of Jo Vandesompele, one of the pre-eminent researchers in the qPCR field.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Licensing Deal Validates Roche IP; Bolsters Life Tech's Ongoing Push into IVD Market
February 23, 2012 / PCR Insider - TATAA Biocenter to Work with Takara Bio on qPCR Training; Offer Roche qPCR Assays
February 23, 2012 / PCR Insider - Report Values Global MDx Market at $11B by 2015; Projects qPCR to Remain Key Driver
February 16, 2012 / PCR Insider - Labcyte, Roche Integrate Liquid Handling, qPCR Tech for Compound Screening Applications
December 8, 2011 / PCR Insider - Expiring Patents, Uptick in Biotech Spending Could Spur qPCR-Based Dx, Tool Development
November 4, 2010 / PCR Insider